DISC-0974 not checked

Disc Medicine, Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
2 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Anemia (2 trials), Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia, Myelofibrosis; Anemia, Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis and 1 more
Main trialPhase 2
“This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.”In the company’s words, NCT07368972 on ClinicalTrials.gov

Other drugs for Anemia

All 94 drugs for Anemia

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Oct 2026 Study of DISC-0974-201 in Participants With IBD and Anemia
Phase 1/2Recruiting May 2027 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Phase 1Completed 30 Jun 2022 Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects
Phase 1Completed 9 Oct 2025 Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow DISC-0974

Following is part of Solo: you see every change to DISC-0974 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in